Relationship of C-reactive protein to adverse cardiovascular events in patients treated by percutaneous coronary intervention for stable angina pectoris

International Heart Journal

Volumn 46, Issue 2, 2005, Pages 195-204

  Veselka, Josef ^a   Procházková, Šárka ^a   Duchoňová, Radka ^a   Homolová, Ingrid ^a   Tesař, David ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Angioplasty; C reactive protein; Inflammation; Stent

Indexed keywords

C REACTIVE PROTEIN; TROPONIN I;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENDER; HEART INFARCTION; HEART MUSCLE INJURY; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INCIDENCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT REFERRAL; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; STABLE ANGINA PECTORIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; BLOOD; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; RADIOGRAPHY; RISK FACTOR; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 23044461171     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.46.195     Document Type: Article

References (24)

1. Aronow WS. C-reactive protein. Should it be considered a coronary risk factor? Geriatrics 2003; 58: 19-22, 25. (Review)
2. Blake GJ, Ridker PM. C-reactive protein and prognosis after percutaneous coronary intervention. Eur Heart J 2002; 23: 923-5.
3. Chew DP, Bhatt DL, Robbins MA, et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 2001; 104: 992-7.
4. de Winter RJ, Koch KT, van Straalen JP, et al. C-reactive protein and coronary events following percutaneous coronary angioplasty. Am J Med 2003; 115: 85-90.
5. de Winter RJ, Heyde GS, Koch KT, et al. The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty. Eur Heart J 2002; 23: 960-6.
6. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363-9.
7. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 2003; 107: 391-7.
8. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-veactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.
9. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N EngI J Med 1997; 336: 973-9.
10. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
11. Torres JL, Ridker PM. Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events. Curr Opin Cardiol 2003; 18: 471-8. (Review)
12. Walter DH, Fichtlscherer S, Britten M, et al. Stalin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation. J Am Coll Cardiol 2001; 38: 2006-12.
13. Winbeck K, Poppert H, Etgen T, Conrad B, Sander D. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 2002; 33: 2459-64.
14. Buffon A, Liuzzo G, Biasucci LM, et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999; 34: 1512-21.
15. Heeschen C, Hamin CW, Bruernmer J, Simoons UL. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. J Am Coll Cardiol 2000; 35:1535-42.
16. Frohlich M, Imhof A, Berg G, et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 2000; 23: 1835-9.
17. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997; 349: 462-6.
18. Tracy RP, Psaty BM, Macy E, et al. Lifetime smoking exposure affects the association of C-creactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vase Biol 1997; 17: 2167-76.
19. Veselka J, Prorchazkova. S, Duchonova R, et al. Relationship of C-reactive protein to presence and severity of coronary atherosclerosis in patients with stable angina pectons or a pathological exercise test.Coron Artery Dis 2002; 13: 151-4.
20. Arroyo-Esphguero R, Avarizas P, Cosin-Sales J, Aldarna G; Pizzi C, Kaski JC. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J 2004; 25: 401-8.
21. Azar RR, Aoun Q Fram DB, Waters DD, Wu AH, Kiernan FK. Relation of C-reactive protein to extent and seventy of coronary narrowing in patients with stable angina pectoris or abnormal exercise test. Am J Cardiol 2000; 86: 205-7.
22. Folsom AR, Pankow JS, Tracy RP, et al. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 2001; 88: 112-7.
23. Johnson BD, Kip KE, Marroquin OC, et al. Semin amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004; 109: 726-32.
24. Gomma. AH, Hirschfield GM, Gallimore JR Jr, Lowe GD, Pepys UB, Fox KM. Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting. Am Heart J 2004; 147: 1071-7.